BioSpace News Archive

According to Coherent Market Insights, the global blood gas analyzers market was valued at US$ 594.6 million in 2017, and is projected to exhibit a CAGR of 5.5% over the forecast period.

Trevor Berry, DC, DABCO announces he will be presenting at the upcoming 2019 Arizona Association of Chiropractic Annual Convention on Friday, June 7 at 2:00 p.m. at the Black Canyon Conference Center in Phoenix.

At the KOL forum, the Company provided an update on the ongoing Phase 1/2 clinical study investigating the front line treatment of VAL-083 with radiation therapy in newly diagnosed MGMT-unmethylated GBM.

Institute collaborates with leading influencers in life sciences to solve industry challenges and provide fresh perspectives

According to Coherent Market Insights, the global small molecule API market was valued at US$ 126.6 million in 2017, and is projected to exhibit a CAGR of 9.1% over the forecast period.

After two years of intensive research and development, significant GI reductions of cane sugar and flour are now a reality

Thermo Scientific software suite delivers enhanced performance, usability and connectivity

According to Coherent Market Insights, the global tissue banking market was valued at US$ 1.04 billion in 2017, and is projected to exhibit a CAGR of 10.8% over the forecast period.

Viracta Therapeutics, Inc. presented updated results today at the 2019 ASCO Annual Meeting from the Ph1b portion of the ongoing Phase 1b/2 clinical trial of nanatinostat in combination with the antiviral valganciclovir for the treatment of relapsed/refractory EBV-associated lymphomas.

MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing potential new therapies for cancer, today announced that updated data presented at ASCO 2019 from a Phase 1b study of investigational ME-401, a selective oral inhibitor of PI3K delta, demonstrate an 80% overall response rate in patients with relapsed or refractory (r/r) follicular lymphoma (FL) (n= 50)